Direkt zum Inhalt

Huebner, G ; Link, H ; Kohne, C H ; Stahl, M ; Kretzschmar, A ; Steinbach, S ; Folprecht, G ; Bernhard, H ; Al-Batran, S E ; Schoffski, P ; Burkart, C ; Kullmann, F ; Otremba, B ; Menges, M ; Hoffmann, M ; Kaiser, U ; Aldaoud, A ; Jahn, A

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

Huebner, G, Link, H, Kohne, C H, Stahl, M, Kretzschmar, A, Steinbach, S, Folprecht, G , Bernhard, H, Al-Batran, S E, Schoffski, P, Burkart, C, Kullmann, F, Otremba, B, Menges, M, Hoffmann, M, Kaiser, U, Aldaoud, A and Jahn, A (2009) Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. British Journal of Cancer 100 (1), pp. 44-49.

Date of publication of this fulltext: 19 Dec 2024 12:11
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleBritish Journal of Cancer
Publisher:NATURE PUBLISHING GROUP
Place of Publication:LONDON
Volume:100
Number of Issue or Book Chapter:1
Page Range:pp. 44-49
Date2009
InstitutionsMedicine > Zentren des Universitätsklinikums Regensburg > Tumorzentrum e.V.
Medicine > Institut für Epidemiologie und Präventivmedizin > Tumorzentrum e.V.
Identification Number
ValueType
10.1038/sj.bjc.6604818DOI
KeywordsCANCER-RESEARCH-NETWORK; CELL LUNG-CANCER; PRIMARY SITE; PRIMARY TUMORS; CHEMOTHERAPY; EPIDEMIOLOGY; COMBINATION; CISPLATIN; ETOPOSIDE; DOCETAXEL; neoplasms; unknown primary; randomized controlled trial; clinical trial, phase II; medical oncology; anti-neoplastic-combined chemotherapy protocols
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID67479

Export bibliographical data

Owner only: item control page

nach oben